Immunomedics Inc (NASDAQ:IMMU)

3.85
Delayed Data
As of May 01
 +0.25 / +6.94%
Today’s Change
3.04
Today|||52-Week Range
5.48
-19.79%
Year-to-Date

Today’s Trading

Previous close3.60
Today’s open3.62
Day’s range3.62 - 3.86
Volume1,067,766
Average volume (3 months)1,042,541
Market cap$359.5M
Dividend yield--
Data as of 4:00pm ET, 05/01/2015

Growth & Valuation

Earnings growth (last year)-162.50%
Earnings growth (this year)-21.43%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)+82.22%
P/E ratioNM
Price/Sales34.16
Price/Book9.11

Competitors

 Today’s
change
Today’s
% change
LMNSLumenis Ltd-0.19-1.69%
ENTLEntellus Medical Inc-0.20-0.73%
ARDXArdelyx Inc+0.51+4.86%
CUTRCutera Inc+0.26+1.91%
Data as of 4:14pm ET, 05/01/2015

Financials

Next reporting dateMay 6, 2015
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$9.0M
Annual profit (last year)-$35.4M
Net profit margin-391.81%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Scientific &
Medical Officer
David M. Goldenberg
President, Chief Executive Officer &
Director
Cynthia L. Sullivan
Corporate headquarters
Morris Plains, New Jersey

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers